Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 9 results for "centrum broking"

If Nifty slips towards 10,250 traders should initiate fresh lo...

We won’t initiate short in the index and rather be on sidelines for next couple of sessions, Jay Purohit, Technical Derivatives Analyst, Centrum Broking Limited, said in an exclusive interview with Moneycontrol’s Kshitij Anand. Money Control, 2 days ago

1 images for "centrum broking"

MSN India, 2 months ago

Top 4 stocks to buy in Diwali week that could give up to 50% return in next 2-3 months

Going ahead, buy on dips strategy in the stocks will provide better risk-reward opportunity, Centrum Broking#39;s Jay Purohit tells Moneycontrol.
 Money Control1 month ago
Rediff.com

Why cement prices will remain flat. 3 reasons

Sector analysts opined that the northern, central and eastern markets were particularly hit The Goods and Services Tax (GST) and Real Estate (Regulation and Development) Act, 2016 (Rera) implementation, together with good monsoons, cooled off cement prices across the country by 2-3 per cent on an average in the immediate months of the new tax regime. It is expected that prices will continue to remain low during the second quarter until the bulk of cement dealers move over to the new tax ...
 Rediff.com2 months ago

UPDATE 2-Top lender SBI's results signal Indian banks' record bad loans peaking

* SBI Q2 net profit 15.82 bln rupees vs 5.57 bln loss yr ago * Shares jump over 6 pct on improved bad loan performance * Other Indian lenders have also seen bad loan additionsslowing * Bank to further improve provision coverage ratio - SBIchairman(Adds SBI ...
 Sify4 days ago Top lender SBI's results signal Indian banks' record bad loans peaking  Sify4 days ago

HDFC Life: subscribe for long-term

City: Mumbai Private life insurer HDFC Life Insurance will launch its Rs 8,700 crore IPO on Tuesday. The price band has been fixed from Rs 275 to Rs 290 per share. At the upper end of the price brand, the insurer has been valued at Rs 58,260 crore. The issue ...
 The Financial Chronicle1 week ago

Re-rating likely of pharma stocks

The BSE Healthcare index has been one of the biggest gainers over the past few days, on easing of regulatory concerns, improving visibility over product launches and a return of growth in the domestic market.Ranjit Kapadia of Centrum Broking believes there ...
 Business Standard1 month ago
Rediff.com

Why GSK is changing its strategy after 93 years

Increased price control over branded generic medicines has affected its profitability GlaxoSmithKline (GSK) Pharmaceuticals is scouting for acquisitions in the domestic market for the first time since it started its operations in the country 93 years ago. The change in strategy comes at a time when the government’ increasing price control over branded generic medicines has affected its profitability.   In the last five years, the revenue of the UK-headquartered company recorded a ...
 Rediff.com2 months ago

With FPIs selling on dips, Nifty may find the going tough

Ravi Ranjan Prasad City: Mumbai With the first quarter results season getting over and no major events lined up for this week, foreign portfolio investors’ profit booking last week and their bearish bets in the futures & options market have come into the ...
 The Financial Chronicle2 months ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less